{'fraction_non_alphanumeric': 0.016556291390728478, 'fraction_numerical': 0.0, 'mean_word_length': 5.46524064171123, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Input of Patients for New Diabetes Technology Products

When companies are developing new products for people with diabetes (PwD), numerous factors drive decisions about what the specifications shall be, which features should be included, and how the product should appear. Traditionally, the necessary information to determine how these decisions are made has come from a limited number of in-person interactions between industry representatives and either patients and/or healthcare professionals (HCPs). This user information is valuable to manufacturers because product features and design features are critically important, because they determine what is needed to make the product successful. Features of diabetes products that receive favorable reviews by PwD and HCPs that are representative of the widespread population of patients and professionals are likely to result in success in the marketplace. It is important to incorporate the views of many stakeholders before a product is launched, but the views of the users—which might be quite diverse—must play a key role in such development processes. Four types of input that are necessary before a final iteration of a product is launched include: